Roger Fu
18Patents
8h-index
20Co-inventors
72Inventor score
Filing activity: Dec 5, 1994 → Dec 12, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8415401B2 | Oral pharmaceutical dosage forms | Human Necessities | 58 | Active |
| US8951556B2 | Oral drug delivery system | Human Necessities | 30 | Active |
| US8945614B2 | Oral drug delivery system | Human Necessities | 30 | Active |
| US8974821B2 | Oral drug delivery system | Human Necessities | 27 | Active |
| US9233160B2 | Oral drug delivery system | Human Necessities | 26 | Active |
| US6025326A | Compositions and methods for the prevention and treatment of oral mucositis | Human Necessities | 21 | Expired |
| US9517271B2 | Oral drug delivery system | Human Necessities | 21 | Active |
| US5543408A | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof | Human Necessities | 20 | Expired |
| US9592204B2 | Oral pharmaceutical dosage forms | Human Necessities | 8 | Active |
| US9572885B2 | Compositions with a rheological modifier to reduce dissolution variability | Human Necessities | 7 | Active |
| US9655861B2 | Oral pharmaceutical dosage forms | Human Necessities | 6 | Active |
| US9555113B2 | Compositions with a rheological modifier to reduce dissolution variability | Human Necessities | 5 | Active |
| US5545637A | Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts | Human Necessities | 4 | Expired |
| US9855333B2 | Compositions with a rheological modifier to reduce dissolution variability | Human Necessities | 2 | Active |
| US10300142B2 | Compositions with a rheological modifier to reduce dissolution variability | Human Necessities | 0 | Active |
| US9907851B2 | Compositions with a rheological modifier to reduce dissolution variability | Human Necessities | 0 | Active |
| US9918982B2 | Oral drug delivery system | Human Necessities | 0 | Active |
| US10206883B2 | Oral pharamaceutical dosage forms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.